Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 52.81 million. The enterprise value is 61.40 million.

Market Cap	52.81M
Enterprise Value	61.40M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 192.04 million shares outstanding. The number of shares has increased by 24.92% in one year.

Current Share Class	n/a
Shares Outstanding	192.04M
Shares Change (YoY)	+24.92%
Shares Change (QoQ)	-12.97%
Owned by Insiders (%)	56.26%
Owned by Institutions (%)	3.07%
Float	61.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	27.50
PS Ratio	1.11
PB Ratio	2.47
P/TBV Ratio	2.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 74.07, with an EV/FCF ratio of -39.11.

EV / Earnings	-38.55
EV / Sales	1.30
EV / EBITDA	74.07
EV / EBIT	n/a
EV / FCF	-39.11

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.59.

Current Ratio	1.21
Quick Ratio	0.63
Debt / Equity	0.59
Debt / EBITDA	15.15
Debt / FCF	-8.00
Interest Coverage	-0.55

Financial Efficiency

Return on equity (ROE) is -8.08% and return on invested capital (ROIC) is -0.97%.

Return on Equity (ROE)	-8.08%
Return on Assets (ROA)	-0.67%
Return on Invested Capital (ROIC)	-0.97%
Return on Capital Employed (ROCE)	-2.16%
Revenue Per Employee	305,639
Profits Per Employee	-10,277
Employee Count	155
Asset Turnover	1.07
Inventory Turnover	1.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.48
52-Week Price Change	n/a
50-Day Moving Average	0.29
200-Day Moving Average	0.29
Relative Strength Index (RSI)	35.22
Average Volume (20 Days)	63,374

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 47.37 million and -1.59 million in losses. Loss per share was -0.01.

Revenue	47.37M
Gross Profit	24.92M
Operating Income	-477,000
Pretax Income	-1.30M
Net Income	-1.59M
EBITDA	15,000
EBIT	-477,000
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 3.96 million in cash and 12.56 million in debt, giving a net cash position of -8.59 million or -0.04 per share.

Cash & Cash Equivalents	3.96M
Total Debt	12.56M
Net Cash	-8.59M
Net Cash Per Share	-0.04
Equity (Book Value)	21.39M
Book Value Per Share	0.11
Working Capital	5.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.30 million and capital expenditures -273,000, giving a free cash flow of -1.57 million.

Operating Cash Flow	-1.30M
Capital Expenditures	-273,000
Free Cash Flow	-1.57M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 52.61%, with operating and profit margins of -1.01% and -3.36%.

Gross Margin	52.61%
Operating Margin	-1.01%
Pretax Margin	-2.75%
Profit Margin	-3.36%
EBITDA Margin	0.03%
EBIT Margin	-1.01%
FCF Margin	n/a

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.92%
Shareholder Yield	-24.92%
Earnings Yield	-3.02%
FCF Yield	-2.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Compumedics has an Altman Z-Score of 1.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	n/a